HOME >> BIOLOGY >> NEWS
Work begins on powering a sustainable future for the UK

Work is getting underway to take the UK into a significantly more sustainable way of meeting its energy needs for the future.

Four Consortia, set up earlier this year under the SUPERGEN initiative, will now start working at ways of improving the UK's renewable power generation and supply systems. These collaborations are covering the areas of Marine Energy, Networks & Power Control, Hydrogen Energy & Storage and Biomass & Biofuels.

SUPERGEN is managed by the Engineering and Physical Sciences Research Council.

The inauguration keynote address will be given by Stephen Timms MP, Minister for Energy, e-Commerce and Postal Services.

The SUPERGEN initiative was launched in September 2001. It is investing more than 25M over five years in sustainable power generation. These four virtual centres are the first to be funded through this initiative and each will run for four years.

This research cuts across many disciplines incorporating political, social, environmental and economic factors covering climate change, fossil fuel extraction rates, emissions control and increasing public awareness of environmental concerns.

The multidisciplinary nature of this research is reflected in the fact that the EPSRC is managing the SUPERGEN initiative working with the Biotechnology and Biological Sciences Research Council (BBSRC), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC).

Each Consortia brings together leading researchers working alongside industry. A key element of the SUPERGEN philosophy is that interaction with industry will lead to "real world" problems being addressed.

It will also be announced at the event that the Carbon Vision Partnership will be investing 4 6 M over the next 3 4 years in R&D focused on the generation and supply of low carbon power. This investment will be channelled through SUPERGEN, and will increase the R&D investment in this key
'"/>

Contact: Jane Reck
jane.reck@epsrc.ac.uk
01-793-444-312
Engineering and Physical Sciences Research Council
11-Nov-2003


Page: 1 2 3 4

Related biology news :

1. New hydrothermal vents discovered as South Pacific Odyssey research begins
2. DCI donor services begins distribution of tissue implants
3. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
4. As autumn approaches, this chickadees brain begins to expand
5. New study begins to unravel fate of toxic pollutants harbored in Arctic waters
6. UCSF begins distributing the first of its two embryonic stem cell lines
7. Acorda Therapeutics begins Phase 3 trials of Fampridine-SR for chronic spinal cord injury
8. Nabi Biopharmaceuticals begins human testing of novel vaccine to fight nicotine addiction
9. The pathway to anxiety begins early in life
10. DOE begins international effort to sequence tree genome
11. Montana State University begins major trout and salmonid book collection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Work begins powering sustainable future for the

(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/26/2015)... TORONTO , March 26, 2015 ... premier family, social, recreation and athletic club, today announced ... designed to allow freedom of movement for members and ... "Following a comprehensive process, we selected FST,s IMID ... sophistication and convenience for our members and staff, in ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
(Date:4/20/2015)... British Columbia and MENLO ... --  DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar ... developing and commercializing proven cancer therapies in new ... at the 106th Annual Meeting of the ... Meeting on the potential for its lead product ...
(Date:4/20/2015)... , April 20, 2015  Eli Lilly and ... data from several targeted cancer therapies, reflecting Lilly,s diverse ... (AACR) Annual Meeting 2015, held April 18-22 in ... Cancer Discoveries to Patients" is the theme of this ... Lilly,s commitment to broadening its portfolio of therapies that ...
(Date:4/20/2015)... --  Meditope Biosciences, Inc ., a biotechnology company developing ... presentation of data demonstrating the use of its SnAP ... data were presented in an abstract at the AACR ... Philadelphia . "We are ... many commercial applications that may be possible for our ...
(Date:4/17/2015)... Reed Technology and Information Services Inc. ... and submission to the U.S. Food and Drug Administration ... Distribution Report (LDR) service for manufacturers of biologics, including ... FDA’s new rule on electronic submission of LDRs. ... and timing of particular biologics introduced to the marketplace, ...
Breaking Biology Technology:DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3
Cached News: